Arkolith/Insider Trading/AGRX/Form 4

Fischer Seth H. Z.

DirectorAGILE THERAPEUTICS INC (AGRX) · full profile →Form 4 · filed Jun 9, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 8, 2023Grant(A)935—$0976

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 8, 2023Grant(A)1K—$01K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000929638-23-001712) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML